Cancer Discov
Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Renal Cell
Dr. Ginna G. Laport, MD
NPI1144370743
- Part D claims, 2016
- 33
- Publications
- 62
- Clinical trials
- 14
- Industry payments
- $116
- State license
- 1
- Practice address
- 300 Pasteur Dr, Stanford, CA 94305-5623
- Practice phone
- Call (650) 723-0822
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Laport's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Ginna G. Laport is a hematologist and oncologist in Stanford, California
Dr. Laport practices in Stanford, California.
Dr. Laport's NPI, 1144370743, was assigned on January 12, 2007. Dr. Laport graduated from McGovern Medical School in 1990. Dr. Laport holds California license A51963.
NPI and contact details
- NPI
- 1144370743NPI Registry (opens in a new tab)
- NPI enumeration date
- January 12, 2007
- NPI status
- Active
- Practice phone
- (650) 723-0822
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Ginna G. Laport's practice address is in Stanford, California
Dr. Laport's practice address in the NPI Registry is 300 Pasteur Dr, Stanford, CA 94305-5623. The practice phone is (650) 723-0822.
- NPI Registry address300 Pasteur Dr, Stanford, CA 94305-5623Phone(650) 723-0822
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Ginna G. Laport's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Laport practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Laport's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Laport practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Ginna G. Laport is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Laport's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Laport is licensed in California.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
Hematologists and oncologists near Dr. Laport
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Ginna G. Laport wrote 33 Medicare Part D claims in 2016
In 2016, Dr. Laport wrote 33 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $412 in total drug cost.
Part D claims, 201633
Drugs named by CMS1
Total drug cost$412
Dr. Laport's most prescribed drugs by claims, 2016
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Laport by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Ginna G. Laport has 62 publications on record
Dmand AI links 62 papers to Dr. Laport, published from 2003 to 2019. 2011 was the busiest year, with 7. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Transplantation, Homologous. Dr. Laport has published most often in Biol Blood Marrow Transplant. Dr. Laport's most frequent co-authors are Robert Stuart Negrin, MD, Robert Lowsky, MD and Sally Arai, MD.
Papers62
Years published2003 to 2019
Dr. Laport's papers by year, 2010 to 2019
Topics Dr. Laport writes about most
- Hematopoietic Stem Cell Transplantation
- Transplantation Conditioning
- Transplantation, Homologous
- Graft vs Host Disease
- Hematologic Neoplasms
- Transplantation, Autologous
- Antineoplastic Combined Chemotherapy Protocols
- Cyclophosphamide
Dr. Laport's most frequent co-authors
- Robert Stuart Negrin, MD23 shared papers
- Robert Lowsky, MD20 shared papers
- Sally Arai, MD14 shared papers
Recent publications by Dr. Laport
Bone Marrow TransplantationGraft vs Host DiseaseHematologic Neoplasms
Biol Blood Marrow Transplant
AllograftsCytokine-Induced Killer CellsHematologic Neoplasms
Support Care Cancer
Adaptation, PsychologicalCancer SurvivorsCaregivers
See who Dr. Laport researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Laport works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Ginna G. Laport has worked on 14 clinical trials
Dmand AI links Dr. Laport to 14 clinical trials, 6 of them phase 2 studies. Conditions studied include Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphoma, Non-Hodgkin and Myeloproliferative Disorders. Stanford University sponsors the most, 7.
Clinical trials with Dr. Laport by phase
- 1Phase 1: 1 trial
- 2Phase 1/2: 2 trials
- 6Phase 2: 6 trials
- 1Phase 2/3: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Laport's trials
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lymphoma, Non-Hodgkin
- Myeloproliferative Disorders
- Graft vs Host Disease
- Lymphoma, Follicular
Investigators on the most trials with Dr. Laport
Recent clinical trials with Dr. Laport
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD (opens in a new tab)
CompletedPhase 1
Graft vs Host DiseaseImmune System DiseasesRegulatory T Cells
Neural Tube DefectsNervous System MalformationsCIK cellsCyclosporineMycophenolate Mofetil
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) (opens in a new tab)
CompletedPhase 3
Disease ProgressionMultiple MyelomaLenalidomideLenalidomide, bortezomib and dexamethasone
Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation (opens in a new tab)
Completed
Social AdjustmentSocial Behavior
Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells (opens in a new tab)
TerminatedPhase 1/2
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloproliferative DisordersRegulatory T-cellsAnti-thymocyte globulin, rabbitCliniMACS CD34 Reagent System
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Ginna G. Laport received $116 in industry payments in 2025
CMS Open Payments shows 1 general payment to Dr. Laport from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Kite Pharma, Inc. paid the most, $116.
Companies that paid Dr. Laport the most, 2025 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Ginna G. Laport has 1 award and honors on record
Dmand AI lists 1 award for Dr. Laport, most recently CMS Stage 1 EHR in 2013.
Awards and honors for Dr. Laport
- 2013
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Ginna G. Laport graduated from McGovern Medical School
Dr. Laport graduated from McGovern Medical School in 1990. Dr. Laport is a member of AACR, ASCO and ASH.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Ginna G. Laport's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Ginna G. Laport
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Ginna G. Laport's NPI number?
Dr. Ginna G. Laport's NPI number is 1144370743. It was assigned on January 12, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Ginna G. Laport?
Dr. Ginna G. Laport is a hematologist and oncologist in Stanford, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Ginna G. Laport practice?
Dr. Laport practices at 300 Pasteur Dr, Stanford, CA 94305-5623.
What is Dr. Ginna G. Laport's office phone number?
The practice phone on file for Dr. Laport is (650) 723-0822.
What is Dr. Ginna G. Laport's medical license number?
Dr. Laport holds California license A51963.
Where did Dr. Ginna G. Laport go to medical school?
Dr. Laport graduated from McGovern Medical School in 1990.
What drugs does Dr. Ginna G. Laport prescribe most?
In 2016 Medicare Part D data, Dr. Laport's most prescribed drugs by claims were Acyclovir.
Has Dr. Ginna G. Laport received payments from drug or device companies?
CMS Open Payments shows $116 in general payments to Dr. Laport from 1 company from 2025 to 2025. The largest total came from Kite Pharma, Inc.
How long has Dr. Ginna G. Laport been practicing?
Dr. Laport graduated from medical school in 1990, 36 years ago.
Does Dr. Ginna G. Laport do research?
Dmand AI links 62 publications to Dr. Laport, published from 2003 to 2019. Dr. Laport has worked on 14 clinical trials.
Who does Dr. Ginna G. Laport publish with?
Dr. Laport's most frequent co-authors are Robert Stuart Negrin, MD (23 shared papers), Robert Lowsky, MD (20 shared papers) and Sally Arai, MD (14 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card